FDA Inspection
Institute of Regenerative and Cellular MedicineInstitute of Regenerative and Cellular Medicine – FDA Inspection, Jan 12, 2016
Record Details
This FDA Inspection record concerns Institute of Regenerative and Cellular Medicine, with an inspection on January 12, 2016, issued by the Center for Biologics Evaluation and Research, covering biologics.
- Inspection Date
- January 12, 2016
- Product Type
- Biologics
View Company Profile
ID · 59f356e7-78c4-4d09-a801-c75ea61a758d
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 950164
- FDA center
- Biologics
- Project area
- Bioresearch Monitoring
FDA Citations
7- 21 CFR 56.115(a)(5)List of members
- 21 CFR 56.115(a)(4)Copies of IRB/CI correspondence
- 21 CFR 56.115(a)(2)Minutes of IRB meetings
- 21 CFR 56.111(a)(4)Informed consent sought
- 21 CFR 56.108(a)(1)Initial and continuing reviews
- 21 CFR 56.108(b)(1)Prompt reporting of unanticipated problems
- 21 CFR 56.113Reporting
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Institute of Regenerative and Cellular Medicine
1| Date | Classification | Office | Project area |
|---|---|---|---|
| October 19, 2021 | VAI | Center for Biologics Evaluation and Research | Bioresearch Monitoring |
Other documents for Institute of Regenerative and Cellular Medicine
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.